Congress Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$690K Hold
5,371
﹤0.01% 317
2026
Q1
$646K Sell
5,371
-565
-10% -$65.2K ﹤0.01% 363
2025
Q4
$625K Sell
5,936
-450
-7% -$42.2K ﹤0.01% 336
2025
Q3
$536K Sell
6,386
-935
-13% -$77K ﹤0.01% 348
2025
Q2
$580K Sell
7,321
-138,113
-95% -$11M ﹤0.01% 336
2025
Q1
$13.1M Buy
145,434
+605
+0.4% +$56.5K 0.1% 170
2024
Q4
$14.4M Buy
144,829
+9,767
+7% +$1.01M 0.1% 167
2024
Q3
$15.3M Sell
135,062
-933
-0.7% -$111K 0.1% 151
2024
Q2
$16.8M Buy
135,995
+182
+0.1% +$23.4K 0.12% 137
2024
Q1
$17.9M Sell
135,813
-3,178
-2% -$392K 0.13% 130
2023
Q4
$15.2M Sell
138,991
-5,235
-4% -$543K 0.12% 137
2023
Q3
$14.8M Buy
144,226
+2,077
+1% +$224K 0.13% 135
2023
Q2
$16.4M Buy
142,149
+1,289
+0.9% +$146K 0.14% 129
2023
Q1
$15M Sell
140,860
-4,219
-3% -$456K 0.14% 135
2022
Q4
$16.1M Buy
145,079
+896
+0.6% +$91.6K 0.16% 118
2022
Q3
$12.4M Buy
144,183
+3,326
+2% +$297K 0.13% 130
2022
Q2
$12.8M Buy
140,857
+4,420
+3% +$392K 0.12% 130
2022
Q1
$11.2M Buy
136,437
+9,006
+7% +$710K 0.1% 158
2021
Q4
$9.77M Sell
127,431
-2,067
-2% -$165K 0.07% 169
2021
Q3
$9.73M Buy
129,498
+3,481
+3% +$265K 0.08% 166
2021
Q2
$9.8M Sell
126,017
-665
-0.5% -$49.5K 0.08% 151
2021
Q1
$9.32M Buy
126,682
+3,498
+3% +$258K 0.08% 137
2020
Q4
$9.62M Buy
123,184
+8,097
+7% +$619K 0.09% 129
2020
Q3
$9.11M Buy
115,087
+2,895
+3% +$227K 0.1% 112
2020
Q2
$8.28M Buy
112,192
+412
+0.4% +$31K 0.1% 111
2020
Q1
$8.21M Buy
111,780
+6,073
+6% +$477K 0.13% 96
2019
Q4
$9.17M Buy
105,707
+4,155
+4% +$341K 0.11% 108
2019
Q3
$8.16M Buy
101,552
+1,811
+2% +$145K 0.11% 104
2019
Q2
$7.98M Buy
99,741
+129
+0.1% +$9.88K 0.1% 113
2019
Q1
$7.91M Buy
99,612
+1,241
+1% +$92.8K 0.1% 114
2018
Q4
$7.17M Buy
98,371
+2,132
+2% +$151K 0.11% 112
2018
Q3
$6.51M Buy
96,239
+2,448
+3% +$156K 0.08% 148
2018
Q2
$5.43M Sell
93,791
-5,446
-5% -$307K 0.07% 160
2018
Q1
$5.16M Buy
99,237
+1,427
+1% +$77.1K 0.07% 168
2017
Q4
$5.25M Sell
97,810
-728,148
-88% -$40.4M 0.08% 160
2017
Q3
$50.5M Buy
825,958
+2,524
+0.3% +$153K 0.78% 67
2017
Q2
$50.4M Sell
823,434
-22,316
-3% -$1.36M 0.9% 57
2017
Q1
$51.3M Sell
845,750
-31,935
-4% -$1.94M 0.98% 59
2016
Q4
$49.3M Sell
877,685
-64,677
-7% -$3.79M 1.03% 53
2016
Q3
$56.1M Sell
942,362
-22,940
-2% -$1.34M 1.24% 18
2016
Q2
$53.1M Sell
965,302
-16,936
-2% -$901K 1.23% 20
2016
Q1
$49.6M Buy
982,238
+54,391
+6% +$2.66M 1.2% 29
2015
Q4
$46.8M Sell
927,847
-73,264
-7% -$3.69M 1.16% 34
2015
Q3
$47.2M Buy
1,001,111
+200,641
+25% +$10.7M 1.21% 31
2015
Q2
$43.5M Buy
800,470
+753,342
+1,599% +$42.3M 1.25% 25
2015
Q1
$2.58M Buy
47,128
+7,625
+19% +$432K 0.06% 163
2014
Q4
$2.14M Buy
39,503
+34,450
+682% +$1.92M 0.05% 172
2014
Q3
$286K Sell
5,053
-49
-1% -$2.75K 0.01% 213
2014
Q2
$282K Buy
5,102
+450
+10% +$24.5K 0.01% 219
2014
Q1
$252K Buy
4,652
+389
+9% +$20.1K 0.01% 225
2013
Q4
$204K Buy
+4,263
New +$195K 0.01% 223

Other funds holding MRK

Congress Asset Management's MRK Position: Q2 2026 in Review

Congress Asset Management held its Merck (MRK) position steady in Q2 2026 at 5,371 shares worth $690K. The position accounts for ﹤0.01% of the portfolio, ranked #317.

Congress Asset Management first reported a position in MRK in Q4 2013 and has held it in 51 quarters since. The position peaked at $56.1M in Q3 2016. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Congress Asset Management held 5,371 shares of Merck worth $690K as of Q2 2026.
  • Congress Asset Management left its Merck share count unchanged in Q2 2026.
  • Merck made up ﹤0.01% of Congress Asset Management's portfolio in Q2 2026, its #317 holding.
  • Congress Asset Management first reported a position in Merck in Q4 2013 and has held it in 51 quarters since.
  • Congress Asset Management's Merck position peaked at $56.1M in Q3 2016.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Congress Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.